Focused-ultrasound developer InSightec has received Health Canada approval for its ExAblate system.
The third-generation version of ExAblate was approved for MR-guided focused ultrasound treatment of uterine fibroids and for pain palliation of bone metastases, according to the firm. It's now available for Canadian patients.

.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=100&q=70&w=100)




.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=167&q=70&w=250)











